AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19590222 — intervention group
Group type: COMPARATOR
Intervention: Voice Hygiene Lecture (VHL)
Number of subjects: 60
Study 16885491 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute counseling session on breastfeeding technique
Number of subjects: 211
Study 15309418 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk (two 100mL portions per day)
Number of subjects: 136
Study 15309418 — intervention group
Group type: COMPARATOR
Intervention: Semi-skimmed milk (one glass per day, control group)
Number of subjects: 136
Study 11359382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent short courses of cyclosporin (Neoral)
Number of subjects: 255
Study 9160938 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral electrical surface stimulation
Number of subjects: 1910
Study 9160938 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation only
Number of subjects: 1910
Study 9160938 — intervention group
Group type: EXPERIMENTAL
Intervention: Bracing for eight hours per day
Number of subjects: 1910
Study 9160938 — intervention group
Group type: EXPERIMENTAL
Intervention: Bracing for sixteen hours per day
Number of subjects: 1910
Study 9160938 — intervention group
Group type: EXPERIMENTAL
Intervention: Bracing for twenty-three hours per day
Number of subjects: 1910
Study 9160938 — intervention group
Group type: EXPERIMENTAL
Intervention: Milwaukee brace
Number of subjects: 1910
Study 9160938 — intervention group
Group type: COMPARATOR
Intervention: Bracing for eight or sixteen hours per day
Number of subjects: 1910
Study 8483862 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive teacher training
Number of subjects: 1232
Study 8483862 — intervention group
Group type: COMPARATOR
Intervention: Brief teacher training
Number of subjects: 1232
Study 8483862 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal intervention
Number of subjects: 1232
Study 8483862 — intervention group
Group type: COMPARATOR
Intervention: No principal intervention
Number of subjects: 1232
Study 8483862 — intervention group
Group type: EXPERIMENTAL
Intervention: Program delivery integrity
Number of subjects: 1232
Study 3307386 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocomponent pertussis toxoid vaccine (JNIH‐7)
Number of subjects: 255
Study 3307386 — intervention group
Group type: COMPARATOR
Intervention: Two-component vaccine (JNIH‐6)
Number of subjects: 255
Study 30326609 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient Powders (MNP) with low iron dose (6 mg/serving)
Number of subjects: 1172
Study 27568011 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance-based exergaming intervention using the Kinect sensor
Number of subjects: 20
Study 27568011 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance training
Number of subjects: 20
Study 24584550 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 210
Study 24584550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 22606361 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma ferritin (<30 µg/L)
Number of subjects: 705
Study 22606361 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma ferritin (<30 µg/L) among HIV-infected patients
Number of subjects: 705
Study 22606361 — intervention group
Group type: EXPERIMENTAL
Intervention: High plasma ferritin (>150 µg/L for women and >200 µg/L for men)
Number of subjects: 705
Study 20837597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleotide-supplemented formula (31 mg/L)
Number of subjects: 301
Study 20837597 — intervention group
Group type: COMPARATOR
Intervention: Control formula (without nucleotide supplementation)
Number of subjects: 301
Study 18756850 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride level in drinking water sources (0.02 to 0.03 ppm)
Number of subjects: 955
Study 18756850 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental caries prevalence
Number of subjects: 955
Study 18756850 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean DMFT among 19-year-old children
Number of subjects: 955
Study 18756850 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries experience
Number of subjects: 955
Study 16047554 — intervention group
Group type: EXPERIMENTAL
Intervention: Chunghyul‐dan 1200 mg once a day for 2 weeks
Number of subjects: 28
Study 16047554 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 28
Study 12145067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 100 microg (IT 100 group)
Number of subjects: 150
Study 12145067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 200 microg (IT 200 group)
Number of subjects: 150
Study 12145067 — intervention group
Group type: COMPARATOR
Intervention: Epidural morphine 3 mg (Epidural group)
Number of subjects: 150
Study 12145067 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study 10329080 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 533
Study 10329080 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 533
Study 7757315 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (400 mg)
Number of subjects: 12
Study 7757315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2317162 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat, high cholesterol diet
Number of subjects: 110
Study 2317162 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat, low cholesterol diet intervention
Number of subjects: 110
Study 2317162 — intervention group
Group type: EXPERIMENTAL
Intervention: Switchback diet
Number of subjects: 110
Study 7461011 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol (1, 2, or 4 microgram/min)
Number of subjects: 24
Study 7461011 — intervention group
Group type: EXPERIMENTAL
Intervention: ritodrine (100, 200, or 400 microgram/min)
Number of subjects: 24
Study 7461011 — intervention group
Group type: COMPARATOR
Intervention: fenoterol and ritodrine
Number of subjects: 24
Study 31915207 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive endoscopic ICH evacuation
Number of subjects: 100
Study 30086761 — intervention group
Group type: EXPERIMENTAL
Intervention: Canine Bud Extraction (CBE)
Number of subjects: 298
Study 27332902 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 1214
Study 27332902 — intervention group
Group type: COMPARATOR
Intervention: AVD (omit bleomycin)
Number of subjects: 1214
Study 27332902 — intervention group
Group type: EXPERIMENTAL
Intervention: BEACOPP (for patients with positive PET findings)
Number of subjects: 1214
Study 27332902 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all patients)
Number of subjects: 1214
Study 24952307 — intervention group
Group type: EXPERIMENTAL
Intervention: Abagovomab
Number of subjects: 129
Study 24952307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 23117550 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic MSCs
Number of subjects: 30
Study 23117550 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous MSCs
Number of subjects: 30
Study 23117550 — intervention group
Group type: COMPARATOR
Intervention: Both Allogeneic and Autologous MSCs
Number of subjects: 30
Study 23117550 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose concentration MSCs (20 million cells)
Number of subjects: 30
Study 21176657 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 60
Study 21176657 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60
Study 21176657 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 60
Study 18728909 — intervention group
Group type: EXPERIMENTAL
Intervention: rapidly forward‐rotating shift system
Number of subjects: 84
Study 18728909 — intervention group
Group type: EXPERIMENTAL
Intervention: flexible shift system
Number of subjects: 84
Study 18728909 — intervention group
Group type: COMPARATOR
Intervention: old shift system
Number of subjects: 84
Study 15869128 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative feeding
Number of subjects: 51
Study 15869128 — intervention group
Group type: COMPARATOR
Intervention: Traditional postoperative feeding
Number of subjects: 51
Study 12872612 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination bi-layer tablet (Quadroplus)
Number of subjects: 12
Study 12872612 — intervention group
Group type: COMPARATOR
Intervention: Tablets containing solely spirapril hydrochloride monohydrate (Quadropril)
Number of subjects: 12
Study 12872612 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (produced exclusively for study medication)
Number of subjects: 12
Study 11044578 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen receptor mRNA expression in hippocampal tissue
Number of subjects: 42
Study 8644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Prick test with 10% fluorescein solution
Number of subjects: 1500
Study 8644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Prick test with 1.0% fluorescein solution
Number of subjects: 1500
Study 8644545 — intervention group
Group type: COMPARATOR
Intervention: Intradermal skin test with 10% fluorescein solution
Number of subjects: 1500
Study 8644545 — intervention group
Group type: COMPARATOR
Intervention: Intradermal skin test with 0.1% fluorescein solution
Number of subjects: 1500
Study 8644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescein angiography (FAG)
Number of subjects: 1500
Study 8644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse reactions (nausea, cough, cold sweat, urticaria, shock)
Number of subjects: 1500
Study 8644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical anaphylactoid shock
Number of subjects: 1500
Study 1338232 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy
Number of subjects: 35
Study 6704973 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous tumor cells plus Bacillus Calmette‐Guérin vaccine
Number of subjects: 24
Study 6704973 — intervention group
Group type: COMPARATOR
Intervention: Normal tissue control (autologous normal mucosa)
Number of subjects: 24
Study 6704973 — intervention group
Group type: COMPARATOR
Intervention: Nonimmunized control patients
Number of subjects: 24
Study 31868565 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% urea cream
Number of subjects: 0
Study 31868565 — intervention group
Group type: COMPARATOR
Intervention: 0.025% tretinoin cream
Number of subjects: 0
Study 31225906 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative PET/CT
Number of subjects: 112
Study 28530513 — intervention group
Group type: COMPARATOR
Intervention: Pre-invitation leaflet
Number of subjects: 20105
Study 28530513 — intervention group
Group type: COMPARATOR
Intervention: Online booking
Number of subjects: 20105
Study 28530513 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sample kits sent unrequested
Number of subjects: 20105
Study 28530513 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed appointments
Number of subjects: 20105
Study 28530513 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse navigator
Number of subjects: 20105
Study 28530513 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sample kits on request
Number of subjects: 20105
Study 28530513 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between timed appointments and nurse navigator
Number of subjects: 20105
Study 26487668 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 632
Study 26487668 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKAs)
Number of subjects: 632
Study 25741456 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study 25741456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22574591 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuxuening Injection (SI), 15 mL by intravenous dripping, twice daily for 14 days
Number of subjects: 79
Study 22574591 — intervention group
Group type: COMPARATOR
Intervention: Routine therapies for COPD (Control)
Number of subjects: 79
Study 22574591 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuxuening Injection (SI)
Number of subjects: 79
Study 20367846 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study 20367846 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0
Study 19093172 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 0
Study 19093172 — intervention group
Group type: COMPARATOR
Intervention: Esophagectomy with three-field lymph node dissection
Number of subjects: 0
Study 16013622 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated video feedback over 3 consecutive weekly practice sessions
Number of subjects: 33
Study 16013622 — intervention group
Group type: COMPARATOR
Intervention: No videotaped feedback (control group)
Number of subjects: 33
Study 12052669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecstasy users (MDMA)
Number of subjects: 94
Study 12052669 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 94
Study 10606227 — intervention group
Group type: EXPERIMENTAL
Intervention: V89L polymorphism (leu/val and leu/leu genotypes)
Number of subjects: 799
Study 10606227 — intervention group
Group type: COMPARATOR
Intervention: AAG levels
Number of subjects: 799
Study 8959943 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (3-6 g daily)
Number of subjects: 38
Study 1797517 — intervention group
Group type: COMPARATOR
Intervention: Lottery tickets for CO reduction (0-3 tickets per day based on CO reduction)
Number of subjects: 0
Study 1797517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum and lottery tickets (up to 5 tickets per night for CO < 10 ppm)
Number of subjects: 0
Study 1797517 — intervention group
Group type: EXPERIMENTAL
Intervention: Special reinforcement schedules (up to 20 tickets per night for CO < 10 ppm)
Number of subjects: 0
Study 6720626 — intervention group
Group type: EXPERIMENTAL
Intervention: High P/S ratio diet for 6 weeks followed by low P/S ratio diet for 6 weeks
Number of subjects: 3
Study 6720626 — intervention group
Group type: COMPARATOR
Intervention: Low P/S ratio diet for 12 weeks
Number of subjects: 3
Study 6720626 — intervention group
Group type: EXPERIMENTAL
Intervention: Low P/S ratio diet for 6 weeks followed by high P/S ratio diet for 6 weeks
Number of subjects: 3
Study 30421019 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision tree model using contrast-enhanced MRI-derived quantitative radiomic features
Number of subjects: 66
Study 30421019 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision tree model with two features (S(1, -1) Entropy and S(2, -2) SumAverg)
Number of subjects: 66
Study 29727906 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg dapagliflozin for one month (TP1)
Number of subjects: 26
Study 29727906 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg saxagliptin for one month (TP2)
Number of subjects: 26
Study 29727906 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin and saxagliptin combination
Number of subjects: 26
Study 29727906 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control during TP2)
Number of subjects: 26
Study 27565832 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally Adapted Motivational Interviewing (CAMI)
Number of subjects: 257
Study 27565832 — intervention group
Group type: COMPARATOR
Intervention: Motivational Interviewing (MI)
Number of subjects: 257
Study 24710957 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium 0.6 mg·kg(‐1) with sugammadex 4.0 mg·kg(‐1)
Number of subjects: 150
Study 24710957 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine 1.0 mg·kg(‐1)
Number of subjects: 150
Study 24710957 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium followed by sugammadex
Number of subjects: 150
Study 24710957 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine
Number of subjects: 150
Study 20009394 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin-based triple therapy
Number of subjects: 772
Study 20009394 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin-based triple therapy
Number of subjects: 772
Study 15037942 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 0
Study 15037942 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11679006 — intervention group
Group type: EXPERIMENTAL
Intervention: tazarotene gel 0.1%
Number of subjects: 24
Study 11679006 — intervention group
Group type: EXPERIMENTAL
Intervention: tazarotene vehicle
Number of subjects: 24
Study 11679006 — intervention group
Group type: COMPARATOR
Intervention: diflorasone diacetate 0.05% ointment
Number of subjects: 24
Study 11679006 — intervention group
Group type: EXPERIMENTAL
Intervention: diflorasone diacetate 0.05% ointment + tazarotene gel 0.1%
Number of subjects: 24
Study 9490342 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoton (4 different schemes) administered in the acute period of MI to 97 patients.
Number of subjects: 174
Study 7965552 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC/essential oil rinse (two variations)
Number of subjects: 200
Study 7965552 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer product
Number of subjects: 200
Study 7965552 — intervention group
Group type: COMPARATOR
Intervention: Hydroalcohol negative control
Number of subjects: 200
Study 2977404 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose captopril (6.25 mg twice daily)
Number of subjects: 6
Study 2977404 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose captopril (25 mg twice daily)
Number of subjects: 6
Study 2977404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31020392 — intervention group
Group type: COMPARATOR
Intervention: Homoeopaths (hom)
Number of subjects: 144
Study 31020392 — intervention group
Group type: COMPARATOR
Intervention: Nutritional Therapists (NT)
Number of subjects: 144
Study 30113228 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide
Number of subjects: 387
Study 27364808 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care model (offsite depression care team)
Number of subjects: 263
Study 24325386 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine (1000 mg oral solution twice daily for 4 weeks)
Number of subjects: 116
Study 24325386 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 mL oral solution twice daily for 4 weeks)
Number of subjects: 116
Study 22390884 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire osteosynthesis
Number of subjects: 80
Study 22390884 — intervention group
Group type: COMPARATOR
Intervention: Mini plate osteosynthesis
Number of subjects: 80
Study 19022322 — intervention group
Group type: EXPERIMENTAL
Intervention: Smallpox vaccination
Number of subjects: 90
Study 17869987 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene oxide sterilization (E1 group - once, E2 group - twice, E3 group - three times)
Number of subjects: 0
Study 17869987 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutaraldehyde sterilization (G1 group - 150 minutes, G2 group - 300 minutes, G3 group - 450 minutes, G4 group - 600 minutes)
Number of subjects: 0
Study 17869987 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated ETTs)
Number of subjects: 0
Study 15028552 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate 12-week parent and child treatment
Number of subjects: 47
Study 15028552 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment condition (control)
Number of subjects: 47
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (amoxicillin, clarithromycin, pantoprazole)
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (tinidazole, clarithromycin, ranitidine bismuth citrate)
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (tinidazole, clarithromycin, pantoprazole)
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (tinidazole, tetracycline, bismuth, pantoprazole)
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapies
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori reinfection in IDDM patients
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily insulin requirement in re-infected IDDM patients
Number of subjects: 116
Study 11404721 — intervention group
Group type: EXPERIMENTAL
Intervention: Glicate haemoglobin in re-infected IDDM patients
Number of subjects: 116
Study 9591000 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 200
Study 9591000 — intervention group
Group type: COMPARATOR
Intervention: Small incision cholecystectomy (SC)
Number of subjects: 200
Study 9591000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 200
Study 7869318 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal method of measurement
Number of subjects: 70
Study 7869318 — intervention group
Group type: COMPARATOR
Intervention: Aggregate method of measurement
Number of subjects: 70
Study 3337028 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified formula (1.6 mg Fe/100 kcal)
Number of subjects: 2
Study 3337028 — intervention group
Group type: COMPARATOR
Intervention: Nonfortified formula
Number of subjects: 2
Study 29392371 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg
Number of subjects: 24
Study 29392371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 27488675 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CAP (bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone)
Number of subjects: 0
Study 27488675 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone)
Number of subjects: 0
Study 25626749 — intervention group
Group type: COMPARATOR
Intervention: Flawless demonstration (F)
Number of subjects: 39